Workflow
6月23日中银创新医疗混合C净值增长1.96%,今年来累计上涨52.32%

Group 1 - The core viewpoint of the news is the performance and holdings of the Zhongyin Innovation Medical Mixed Fund C, which has shown significant growth in recent months and year-to-date [1]. - As of June 23, 2025, the latest net value of the fund is 1.8410 yuan, reflecting a growth of 1.96% [1]. - The fund's one-month return is 8.08%, ranking 100 out of 4699 in its category, while the six-month return is 49.15%, ranking 23 out of 4539 [1]. - Year-to-date, the fund has achieved a return of 52.32%, ranking 28 out of 4559 [1]. Group 2 - The top ten stock holdings of the Zhongyin Innovation Medical Mixed Fund C account for a total of 70.44%, with the largest positions in Kelun-Botai (9.77%), Hengrui Medicine (9.39%), and Innovent Biologics (8.54%) [1]. - The fund was established on October 30, 2020, and as of March 31, 2025, it has a total scale of 1.454 billion yuan [1]. - The fund manager, Zheng Ning, has a background in asset management and has held various positions in the industry since 2022 [2].